Results 211 to 220 of about 7,232 (251)
Some of the next articles are maybe not open access.

A randomised trial to assess the impact of midodrine on early mobilisation after elective primary hip replacement surgery

Anaesthesia and Intensive Care
Early mobilisation following elective total hip arthroplasty (THA) facilitates quicker rehabilitation, and reduces complications and hospital length of stay.
Adam C Cammerman   +3 more
semanticscholar   +1 more source

Abstract FR446: FLUDROCORTISONE VS MIDODRINE FOR ORTHOSTATIC HYPOTENSION: A RETROSPECTIVE COHORT STUDY

HYPERTENSION
Introduction: Orthostatic hypotension (OH) is a debilitating condition commonly observed in patients with impaired vascular tone upon positional changes, often due to neurogenic disorders, liver disease, hypovolemia, or advanced HF.
Muhammad Sabri   +3 more
semanticscholar   +1 more source

Impact of using midodrine for vasopressor weaning in septic shock patients: a randomized controlled trial

Anaesthesia, Pain & Intensive Care
Background & objective: Sepsis and septic shock are almost always associated with severe hypotension. Various vasopressors are being used to treat hypotension. Sometimes process of weaning off intravenous (IV) vasopressors becomes really problematic.
Mohamed Ali Mahmoud   +2 more
semanticscholar   +1 more source

Midodrine

Reactions Weekly, 2023
Jose-Alberto Palma, Horacio Kaufmann
  +4 more sources

Outcomes with inpatient use of midodrine in patients with heart failure and kidney failure on maintenance dialysis

Acta Cardiologica
Background Midodrine, an FDA-approved medication for orthostatic hypotension, is also used off-label to manage hypotension in dialysis patients, including those with heart failure.
Neev Patel   +5 more
semanticscholar   +1 more source

Impacts of rifaximin and midodrine on morbidity, mortality, and quality of life in patients with decompensated liver cirrhosis

European Journal of Gastroenterology and Hepathology
Background Vasodilatation and bacterial dislocation are the main contributors to the catastrophic events in patients with decompensated liver cirrhosis (DLC).
Maha Elsabaawy   +5 more
semanticscholar   +1 more source

Abstract 4137484: Clinical implications of combined midodrine and pulmonary vasodilator therapy in Portopulmonary Hypertension

Circulation
Introduction: Portopulmonary hypertension (POPH) and associated pulmonary vascular resistance (PVR) elevation is seen in the context of underlying portal hypertension and liver disease.
Nicholas Bergeron   +10 more
semanticscholar   +1 more source

Abstract 4147683: The Impact of Midodrine on Heart Failure Outcomes: Emergency Visits, Mortality, and Complications

Circulation
Background: Midodrine, an FDA-approved peripheral alpha1-adrenergic agonist for treating orthostatic hypotension, is also used off-label to manage hypotension in patients with advanced heart failure (HF).
Usman A Akbar   +9 more
semanticscholar   +1 more source

Midodrine

Reactions Weekly, 2021
openaire   +1 more source

Home - About - Disclaimer - Privacy